Keyphrases
Active Ulcerative Colitis
20%
Anti-tumor Necrosis Factor (anti-TNF)
27%
Clinical Remission
34%
Crohn's Disease
80%
Disease Activity
22%
Fecal Calprotectin
31%
Ileal Pouch-anal Anastomosis
27%
Inflammatory Bowel Disease
100%
Israeli
37%
Real-world Experience
20%
Remission Induction
23%
Ulcerative Colitis
58%
Ustekinumab
28%
Vedolizumab
21%
Pharmacology, Toxicology and Pharmaceutical Science
Calgranulin
22%
Cohort Study
22%
Crohn's Disease
57%
Disease Activity
24%
Inflammatory Bowel Disease
60%
Remission
56%
Tumor Necrosis Factor
36%
Ulcerative Colitis
43%
Ustekinumab
28%
Vedolizumab
21%
Medicine and Dentistry
Crohn's Disease
51%
Disease
21%
Disease Activity
31%
Faecal Calprotectin
31%
Ileo-Anal Pouch
20%
Inflammatory Bowel Disease
64%
Patient with Inflammatory Bowel Disease
36%
Tumor Necrosis Factor
35%
Ulcerative Colitis
75%